Growth Metrics

Avadel Pharmaceuticals (AVDL) Shares Outstanding (Diluted Average): 2009-2020

Historic Shares Outstanding (Diluted Average) for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2020 value amounting to $54.9 million.

  • Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) rose 46.89% to $54.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was $54.9 million, marking a year-over-year increase of 46.89%. This contributed to the annual value of $54.9 million for FY2020, which is 46.89% up from last year.
  • As of FY2020, Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $54.9 million, which was up 46.89% from $37.4 million recorded in FY2019.
  • Over the past 5 years, Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) peaked at $54.9 million during FY2020, and registered a low of $37.3 million during FY2018.
  • For the 3-year period, Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) averaged around $43.2 million, with its median value being $37.4 million (2019).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first declined by 10.63% in 2018, then soared by 46.89% in 2020.
  • Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) (Yearly) stood at $41.2 million in 2016, then climbed by 1.25% to $41.8 million in 2017, then dropped by 10.63% to $37.3 million in 2018, then grew by 0.21% to $37.4 million in 2019, then spiked by 46.89% to $54.9 million in 2020.